NCT00780598 2012-06-28
OPAL
Chroma Therapeutics
Phase 2 Completed
Clinical Trials
3 trialsNCT00737555 2012-02-15
A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours
Chroma Therapeutics
Phase 1 Completed
NCT00689000 2010-10-22
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Chroma Therapeutics
Phase 1/2 Completed